Liu, Chun
Yan, Cheng
Zhang, Weichang
Sun, Yuxin
Lin, Youjun
Cai, Wenwu https://orcid.org/0000-0003-0741-7266
Funding for this research was provided by:
National Natural Science Foundation of China (81703767)
Hunan Natural Science Foundation of China (2019JJ50891)
Article History
Received: 18 May 2024
Accepted: 11 April 2025
First Online: 17 April 2025
Declarations
:
: Between January 2018 and January 2023, a research project was implemented to study the capture efficiency of CanPatrol® technique for CTCs in patients with gallbladder adenocarcinoma. Now, the clinical data on patients with aGA were retrospectively reviewed to reveal the clinical significances of CTCs. The requirement for written informed consent was waived owing to the retrospective study design. This study was approved by the Research Ethics Committee of Second Xiangya Hospital (approval No. 179 in 2017) and was performed in accordance with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.